Acute myeloid leukemia (AML) is a disease of older adults, with a median age at diagnosis over 65 years. Studies from real-world practice1 and experimental clinical trials2, 3, 4 have documented that age and frailty are prime predictors of outcome in AML.
Ferrara F, Barosi G, Venditti A, Angelucci E, Gobbi M, Pane F, et al. (2013). Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making. LEUKEMIA, 27, 997-999 [10.1038/leu.2012.303].
Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making.
TOSI, PATRIZIA;ZINZANI, PIER LUIGI;TURA, SANTE
2013
Abstract
Acute myeloid leukemia (AML) is a disease of older adults, with a median age at diagnosis over 65 years. Studies from real-world practice1 and experimental clinical trials2, 3, 4 have documented that age and frailty are prime predictors of outcome in AML.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
